<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestar</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник аритмологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Arrhythmology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-8641</issn><issn pub-type="epub">2658-7327</issn><publisher><publisher-name>НАО «Инкарт»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vestar-555</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ФАКТОРЫ РИСКА РАЗВИТИЯ ИШЕМИЧЕСКОГО ИНСУЛЬТА У БОЛЬНЫХ С ПОСТОЯННОЙ ФОРМОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ</article-title><trans-title-group xml:lang="en"><trans-title>RISK FACTORS OF ISCHEMIC STROKE IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щукин</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchukin</surname><given-names>Yu. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рубаненко</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Rubanenko</surname><given-names>A. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Германов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Germanov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терешина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tereshina</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГБОУ ВПО СамГМУ Минздравсоцразвития России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>22</day><month>09</month><year>2020</year></pub-date><volume>67</volume><issue>67</issue><fpage>20</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Щукин Ю.В., Рубаненко А.О., Германов А.В., Терешина О.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Щукин Ю.В., Рубаненко А.О., Германов А.В., Терешина О.В.</copyright-holder><copyright-holder xml:lang="en">Shchukin Y.V., Rubanenko A.O., Germanov A.V., Tereshina O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestar.elpub.ru/jour/article/view/555">https://vestar.elpub.ru/jour/article/view/555</self-uri><abstract><p>С целью выявления гемостазиологических, гемодинамических и генетических показателей, ассоциированных с риском развития ишемического инсульта у больных с постоянной формой фибрилляции предсердий, обследовано 103 больных ишемической болезнью сердца, из них 60 мужчин и 43 женщины (средний возраст - 60,4±4,5 лет).</p></abstract><trans-abstract xml:lang="en"><p>To reveal hemostatic, hemodynamic, and genetic indices associated with a high risk of ischemic stroke in patients with chronic atrial fibrillation, 103 patients with coronary artery disease and chronic AF (60 men, 43 women) aged 60.4±4.5 years were examined.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>фибрилляция предсердий</kwd><kwd>ишемический инсульт</kwd><kwd>ушко левого предсердия</kwd><kwd>спонтанное эхоконтрастирование</kwd><kwd>активируемый тромбином ингибитор фибринолиза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary artery disease</kwd><kwd>atrial fibrillation</kwd><kwd>ischemic stroke</kwd><kwd>left auricle</kwd><kwd>spontaneous echo-contrasting</kwd><kwd>thrombin activated fibrinolysis inhibitor</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines for the management of atrial fibrillation // European Heart Journal. - 2010. - Vol. 31. - P. 2369-2429.</mixed-citation><mixed-citation xml:lang="en">Guidelines for the management of atrial fibrillation // European Heart Journal. - 2010. - Vol. 31. - P. 2369-2429.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation // Europace. - 2006. -№8. - P. 651-745.</mixed-citation><mixed-citation xml:lang="en">ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation // Europace. - 2006. -№8. - P. 651-745.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Панченко Е.П. Профилактика тромбоэмболий у больных мерцательной аритмией / Е.П.Панченко, Е.С.Кропачева. - М.: OOO «Медицинское информационное агентство», 2007. - 144 с.</mixed-citation><mixed-citation xml:lang="en">Панченко Е.П. Профилактика тромбоэмболий у больных мерцательной аритмией / Е.П.Панченко, Е.С.Кропачева. - М.: OOO «Медицинское информационное агентство», 2007. - 144 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis / L.Sanglas [et al.] // Molecular Cell. - 2008. - № 4. - P. 598-606.</mixed-citation><mixed-citation xml:lang="en">Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis / L.Sanglas [et al.] // Molecular Cell. - 2008. - № 4. - P. 598-606.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis / P.Miljic [et al.] // Srp. Arh. Celok. Lek. - 2010. Vol. 138. - Suppl 1. - P. 74-78.</mixed-citation><mixed-citation xml:lang="en">Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis / P.Miljic [et al.] // Srp. Arh. Celok. Lek. - 2010. Vol. 138. - Suppl 1. - P. 74-78.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays / V.Schroeder [et al.] // Thromb. Haemost. - 2006. - № 2. - P. 236-237.</mixed-citation><mixed-citation xml:lang="en">TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays / V.Schroeder [et al.] // Thromb. Haemost. - 2006. - № 2. - P. 236-237.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men / M.E.Meltzer [et al.] // Haematologica. - 2009. № 6. P. 811-818.</mixed-citation><mixed-citation xml:lang="en">Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men / M.E.Meltzer [et al.] // Haematologica. - 2009. № 6. P. 811-818.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ilhan D. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke / D.Ilhan, D.Ozbabalik, E.Gulcan // Neurologist. - 2010. - №3. - P. 188-191.</mixed-citation><mixed-citation xml:lang="en">Ilhan D. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke / D.Ilhan, D.Ozbabalik, E.Gulcan // Neurologist. - 2010. - №3. - P. 188-191.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Meltzer M.E. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 / M.E.Meltzer, T.Lisman, P.G. de Groot // Blood. - 2010. - №1. - P. 113-121.</mixed-citation><mixed-citation xml:lang="en">Meltzer M.E. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 / M.E.Meltzer, T.Lisman, P.G. de Groot // Blood. - 2010. - №1. - P. 113-121.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection) / Y.Wang [et al.] // Circulation. - 2006. - Vol. 113. - № 12. - P. 1615 - 1621.</mixed-citation><mixed-citation xml:lang="en">VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection) / Y.Wang [et al.] // Circulation. - 2006. - Vol. 113. - № 12. - P. 1615 - 1621.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Common VKORC1 variants are not associated with arterial or venous thrombosis / L.A.Hindorff [et al.] // J Thromb Haemost. - 2007. - №5. - P. 2025-2027.</mixed-citation><mixed-citation xml:lang="en">Common VKORC1 variants are not associated with arterial or venous thrombosis / L.A.Hindorff [et al.] // J Thromb Haemost. - 2007. - №5. - P. 2025-2027.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers / J.Montaner [et al.] // Stroke. - 2008. - № 8. - P. 2280 - 2287.</mixed-citation><mixed-citation xml:lang="en">Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers / J.Montaner [et al.] // Stroke. - 2008. - № 8. - P. 2280 - 2287.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Watson, T. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation / T. Watson, E.Shantsila, GY.Lip // Int J Cardiol. - 2007. - № 9. - P. 123124</mixed-citation><mixed-citation xml:lang="en">Watson, T. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation / T. Watson, E.Shantsila, GY.Lip // Int J Cardiol. - 2007. - № 9. - P. 123124</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Echocardiographic predictors of left atrial appendage thrombus formation / S.Ayirala [et al.] // J Am Soc Echocardiogr. - 2011. - Vol. 24. - № 5. - P. 499-505.</mixed-citation><mixed-citation xml:lang="en">Echocardiographic predictors of left atrial appendage thrombus formation / S.Ayirala [et al.] // J Am Soc Echocardiogr. - 2011. - Vol. 24. - № 5. - P. 499-505.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis / C.Verstuyft [et al.] // J Thromb Haemost. - 2009. -Vol. 7. - № 6. - P. 1034-1036.</mixed-citation><mixed-citation xml:lang="en">VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis / C.Verstuyft [et al.] // J Thromb Haemost. - 2009. -Vol. 7. - № 6. - P. 1034-1036.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease / DM.Smadja [et al.] // Thromb Haemost. - 2008. - Vol. 99. - № 5. - P. 970 - 972.</mixed-citation><mixed-citation xml:lang="en">No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease / DM.Smadja [et al.] // Thromb Haemost. - 2008. - Vol. 99. - № 5. - P. 970 - 972.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zabalgoitia M. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in non-valvular atrial fibrillation / M.Zabalgoitia, J.L.Halperin, L.A.Pearce // J Am Coll Cardiol. - 1998. - Vol. 31. - P. 1622-1626</mixed-citation><mixed-citation xml:lang="en">Zabalgoitia M. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in non-valvular atrial fibrillation / M.Zabalgoitia, J.L.Halperin, L.A.Pearce // J Am Coll Cardiol. - 1998. - Vol. 31. - P. 1622-1626</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Сердечная Е.В. Дополнительные маркеры риска тромбоэмболического инсульта у больных с фибрилляцией предсердий / Е.В.Сердечная, Т.А.Истомина, Л.А.Кульминская // Экология человека. - 2006. - №19. - С 3742.</mixed-citation><mixed-citation xml:lang="en">Сердечная Е.В. Дополнительные маркеры риска тромбоэмболического инсульта у больных с фибрилляцией предсердий / Е.В.Сердечная, Т.А.Истомина, Л.А.Кульминская // Экология человека. - 2006. - №19. - С 3742.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Pullicino P.M. Stroke in patients with heart failure and reduced left ventricular ejection fraction / P.M.Pullicino, J.L.Halperin, J.L.P.Thompson // Neurology. - 2000. - Vol. 54. -№ 2. - C. 288.</mixed-citation><mixed-citation xml:lang="en">Pullicino P.M. Stroke in patients with heart failure and reduced left ventricular ejection fraction / P.M.Pullicino, J.L.Halperin, J.L.P.Thompson // Neurology. - 2000. - Vol. 54. -№ 2. - C. 288.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
